Status:

UNKNOWN

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

Lead Sponsor:

Nantes University Hospital

Collaborating Sponsors:

Roche Diagnostics GmbH

Conditions:

Endometrial Neoplasms

Postmenopause

Eligibility:

FEMALE

18+ years

Brief Summary

This study aims to explore the sensitivity of an innovative marker, HE4, in the diagnosis approach of endometrial cancer in case of postmenopausal bleedings.

Detailed Description

Endometrial cancer is the most common pelvic gynecological cancer in France, ranking 5th among cancers in women in terms of incidence. The most frequent symptom is post-menopausal bleeding and is one...

Eligibility Criteria

Inclusion

  • Patient with postmenopausal bleeding
  • Patient requiring hysteroscopy or hysterectomy
  • No objection from the patient to participate in the study

Exclusion

  • Non-menopausal patient
  • Patient under guardianship, curatorship or deprived of her freedom
  • Patient with proven metastases on imaging
  • Patient with a macroscopically suspicious cervix
  • Patient presenting an ovarian cyst or an associated adnexal pathology
  • Patient contraindicated for surgical treatment (therefore not eligible for pathological analysis)
  • Patient who has already been treated with hormone therapy for breast cancer
  • Patient who has already had surgery for this pathology, with a contributing anatomopathological result (we will therefore include patients who would not benefit from an operative hysteroscopy after performing a cornier® pipelle that does not allow a positive result)

Key Trial Info

Start Date :

June 25 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04867109

Start Date

June 25 2021

End Date

September 1 2022

Last Update

September 17 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Saint-Nazaire Hospital

Saint-Nazaire, Loire-Atlantique, France, 44606

2

Vendee Hospital Center

La Roche-sur-Yon, Vendee, France, 85925

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding | DecenTrialz